Products - Chronic kidney disease | Topic | NICE

Showing 7 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
22 January 2025
Sparsentan for treating primary IgA nephropathy [ID6308]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
30 April 2025
Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
13 August 2025
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Iptacopan for treating complement 3 glomerulopathy ID6283
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Dapagliflozin for treating chronic kidney disease [ID6411]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC